DIABETES MELLITUS (version 2)

12345678910
Across
  1. 4. Targeted_______glycaemic control for type-2 diabetes patient is 4.4 -7.0 mmol/L.
  2. 5. The _________effect occurs when an overdose of insulin, particularly an evening or bedtime dose, causes blood glucose to drop too low overnight.
  3. 6. Black box warning for Metformin when used with poor renal function.
  4. 7. Commonly used first-line agent for type-2 diabetes.
  5. 8. Regular________activity is a good way to improve glycemic control in T2DM patients.
  6. 9. Insulin_________is one of the long-acting insulin analogues.
  7. 10. ______diabetes characterised by progressive decline in beta-cell function associated with insulin resistance in muscle and adipose tissue.
Down
  1. 1. ___________(eg: Gliclazide) should be discontinued when bolus insulin is started.
  2. 2. Deficiency that is recognized as uncommon from the long-term complication use of Metformin.
  3. 3. ________occurs when an injection site is overused.